Avenue Therapeutics Inc. (ATXI)
NASDAQ · Healthcare
Avenue Therapeutics Inc. Revenue 2024–2025
Avenue Therapeutics Inc. annual/quarterly revenue history and growth rate from 2024 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Avenue Therapeutics Inc. revenue for the quarter ending September 30, 2025 was 0.
- Avenue Therapeutics Inc. revenue for the twelve months ending September 30, 2025 was 1.4 M.
- Avenue Therapeutics Inc. annual revenue for 2025 was 1.4 M.
- Avenue Therapeutics Inc. annual revenue for 2024 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
Avenue Therapeutics Inc. Market Cap — FAQ
Avenue Therapeutics Inc. (ATXI) market cap over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ATXI's market cap history?
The chart and table above show Avenue Therapeutics Inc.'s market cap by year and by quarter, including the growth rate.